E
Metasphere Labs Inc. LABZ
CNSX
Recommendation
Dividend Power Score
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

Company Overview

Metasphere Labs Inc. is a publicly traded company quoted on the OTC Markets under the ticker LABZ. Based on available public disclosures, the company positions itself within the cannabis and hemp advisory and services industry, with a stated focus on providing consulting, licensing, and operational support services to participants in regulated cannabis markets. The company does not report large-scale product manufacturing or consumer brand operations, and its revenue model has historically been tied to professional services rather than physical goods.

The company traces its origins to an earlier corporate entity and underwent a name change to Metasphere Labs Inc. as part of a strategic repositioning toward cannabis-related advisory activities. Public filings and market disclosures indicate that the company remains in an early-stage or development phase, with limited and inconsistent revenue generation. Data inconclusive based on available public sources regarding sustained competitive advantages or proprietary technology.

Business Operations

Metasphere Labs Inc.’s disclosed operations center on consulting and advisory services, including regulatory compliance guidance, business planning, and licensing support for cannabis operators. The company has also referenced involvement in technology and intellectual property development related to cannabis operations, though public filings do not provide detailed evidence of commercially deployed platforms or scalable technology assets.

Operations appear to be primarily domestic within the United States, with no verified disclosures of material international revenue or overseas subsidiaries. The company has periodically announced intended partnerships and strategic relationships; however, based on SEC filings and OTC disclosures, many of these arrangements have been preliminary or non-material, and ongoing operational impact is unclear. Data inconclusive based on available public sources regarding stable long-term contracts or recurring revenue streams.

Strategic Position & Investments

The company’s stated strategy has focused on gaining exposure to the regulated cannabis sector through asset-light advisory and intellectual property–driven models rather than capital-intensive cultivation or retail operations. Public disclosures reference efforts to identify growth opportunities through licensing agreements, joint ventures, and strategic acquisitions, though few completed transactions have been substantiated through audited filings.

Metasphere Labs Inc. has periodically announced intentions to invest in or collaborate with cannabis-related ventures and brands. However, SEC filings and OTC Markets disclosures indicate that many such initiatives were exploratory, expired, or not financially material. Data inconclusive based on available public sources regarding the scale, performance, or current status of any portfolio investments or subsidiaries.

Geographic Footprint

The company’s disclosed operational focus is within the United States, particularly in states with legalized or regulated cannabis frameworks. Corporate filings list its principal executive offices in the United States, though specific long-term physical facilities or operational hubs are not consistently detailed across reporting periods.

There is no verified evidence from SEC filings or independent financial publications indicating meaningful international operations or foreign revenue contribution. Any references to global or cross-border opportunities appear aspirational rather than reflective of established international market presence.

Leadership & Governance

Public filings identify a small executive leadership structure, consistent with a micro-cap advisory company. Governance and management responsibilities appear to be concentrated among a limited number of officers, with no independent board committees disclosed in recent filings. The company’s leadership has emphasized strategic flexibility and opportunistic participation in emerging cannabis markets, though execution has varied over time.

Key executives disclosed in public filings include:

  • Michael TobiasChief Executive Officer
  • Michael TobiasPresident
  • Michael TobiasChairman of the Board

Data inconclusive based on available public sources regarding broader executive depth, long-term governance framework, or formalized leadership succession planning.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $183.14
B
AAPL NASDAQ $255.76
B
MSFT NASDAQ $401.86
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $125.33
B
Top Financial Stocks
See All »
B
B
JPM NYSE $282.89
B
V NYSE $306.50
Top Energy Stocks
See All »
B
ENB.TO TSX $73.47
B
ENB NYSE $53.63
Top Health Care Stocks
See All »
B
LLY NYSE $977.25
B
JNJ NYSE $242.04
B
AMGN NASDAQ $367.79
Top Real Estate Stocks
See All »
B
PLD NYSE $131.90